《World Journal of Gastroenterology》2008年19期 加入收藏    获取最新 
 A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong,China
   AIM:To investigate the role of hepatitis B virus (HBV) replication in the development of hepatocellular carcinoma (HCC), a nested case-control study was performed to study the relationship between HBV DNA level and risk of HCC. METHODS:One hundred and seventy cases of HCC and 276 control subjects free of HCC and cirrhosis were selected for this study. Serum HBV DNA level was measured using fluorescein quantitative polymerase chain reaction at study entry and the last visit. RESULTS:In a binary unconditional logistic regression analysis adjusted for age, cigarette smoking, alcohol consumption and family history of chronic liver diseases, the adjusted odds ratios (95% confidence intervals) of HCC in patients with increasing HBV DNA level were 2.834 (1.237-6.492), 48.403 (14.392-162.789), 42.252 (14.784-120.750), and 14.819 (6.992-31.411) for HBV DNA levels ≥ 104 to < 105; ≥ 105 to < 106; ≥ 106 to < 107; ≥ 107 copies/mL, respectively. Forty-six HCC cases were selected to compare the serums viral loads of HBV DNA at study entry with those at the last visit. The HBV DNA levels measured at the two time points did not differ significantly.CONCLUSION:The findings of this study provide strong longitudinal evidence of an increased risk of HCC associated with persistent elevation of serum HBV DNA level in the 104-107 range.
【基金】:The National High Technology Research and Development Program of China 863 Project, No. 2006AA02Z4C5
【分类号】:R735.7
【DOI】:CNKI:SUN:ZXXY.0.2008-19-018
【正文快照】:
  INTRODUCTION Chronic hepatitis B virus (HBV) infection is still a worldwide health problem[1], with approximate 400 million patients persistently infected[2,3]. Although most of the HBV carriers are asymptomatic, about one-third (25%-40%) die from cirrhot…
 
 推荐 CAJ下载           PDF下载
 CAJViewer7.0阅读器支持所有CNKI文件格式,AdobeReader仅支持PDF格式
 A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong,China
 Tao-Tao Liu;Ying Fang;Hui Xiong;Tao-Yang Chen;Zheng-Pin Ni;Jian-Feng Luo;Nai-Qing Zhao;Xi-Zhong Shen Department of Gastroenterology;Zhongshan Hospital;Fudan University;Shanghai 200032;China Ying Fang;Endoscopy Center;Huadong Hospital;Fudan University;Shanghai 200040;China Chinese National Human Genome Center at Shanghai;Shanghai 201203;China Qidong Liver Cancer Institute;Qidong 226200;Jiangsu Province;China Department of Health Statistics and Community Medicine;Fudan University;Shanghai 200032;China
  AIM:To investigate the role of hepatitis B virus (HBV) replication in the development of hepatocellular carcinoma (HCC), a nested case-control study was performed to study the relationship between HBV DNA level and risk of HCC. METHODS:One hundred and seventy cases of HCC and 276 control subjects free of HCC and cirrhosis were selected for this study. Serum HBV DNA level was measured using fluorescein quantitative polymerase chain reaction at study entry and the last visit. RESULTS:In a binary unconditional logistic regression analysis adjusted for age, cigarette smoking, alcohol consumption and family history of chronic liver diseases, the adjusted odds ratios (95% confidence intervals) of HCC in patients with increasing HBV DNA level were 2.834 (1.237-6.492), 48.403 (14.392-162.789), 42.252 (14.784-120.750), and 14.819 (6.992-31.411) for HBV DNA levels ≥ 104 to < 105; ≥ 105 to < 106; ≥ 106 to < 107; ≥ 107 copies/mL, respectively. Forty-six HCC cases were selected to compare the serums viral loads of HBV DNA at study entry with those at the last visit. The HBV DNA levels measured at the two time points did not differ significantly.CONCLUSION:The findings of this study provide strong longitudinal evidence of an increased risk of HCC associated with persistent elevation of serum HBV DNA level in the 104-107 range.
【Keyword】:Hepatitis B surface antigen;Viral replication;Asymptomatic carriers;Viral load